Get started
Author

Ikechukwu Okwudili Anigbogu

Observed names: Anigbogu, I. O, Anigbogu, Ikechukwu, I. O. Anigbogu, I.O., Anigbogu, Ikechukwu Anigbogu, Ikechukwu O. Anigbogu
OpenAlex ID: A5112699214
Low awareness of venous thromboembolism among the general population: a call for increased public enlightenment programs.
2021 · Okoye, Helen, Nwagha, Theresa, et al. · Journal of preventive medicine and hygiene · 9
PDF
Cerebral artery conditional blood velocity in sickle cell disease: a multicentre study and evidence for active treatment
2023 · Emmanuel Modebe, Charles Nonyelu, et al. · Archives of Disease in Childhood · 8
PDF
Blood transfusion in Sub-Saharan Africa: Historical perspective, clinical drivers of demand and strategies for increasing availability
2021 · Angela Ogechukwu Ugwu, Anazoeze Jude Madu, et al. · Africa Sanguine · 8
PDF
Effectiveness of blood utilization across departments in a tertiary health institution
2023 · Ikechukwu Okwudili Anigbogu, Ebele Dumebi Muoghalu, et al. · Acta Haematologica Polonica · 5
PDF
The Need to Consider Pro-Active Treatment for Cerebral Artery Conditional Blood Velocity Determined By Transcranial Doppler Ultrasonography (TCD) in Sickle Cell Disease (SCD)
2023 · Iheanyi Okpala, Emmanuel Modebe, et al. · Blood · 5
Phenotypic characterisation and associations of leg ulcers in adult sickle cell patients
2021 · Anazoeze Madu, Kenechi Madu, et al. · Wound Repair and Regeneration · 5
Plasma concentration of fucosyltransferase 7 is not associated with the number of clinically overt vaso-occlusive events in sickle cell disease
2023 · Iheanyi E. Okpala, Onyinye E. Eze, et al. · Ghana Medical Journal · 3
Evaluation of the Pattern and Quality of Referrals from Inpatient Wards to Hematology Department of a Tertiary Hospital in Nigeria
2022 · Angela Ogechukwu Ugwu, Ikechukwu Okwudili Anigbogu · Nigerian Journal of Medicine · 3
Lymphoid Neoplasms and COVID-19 Vaccination
2025 · Onochie Ikenna Obodo, Sunday Ocheni, et al. · Oncology Advances · 1
PDF
Preclinical therapeutics for sickle cell disease: modern developments and future considerations
2025 · Iheanyi Okpala, Charles Nonyelu, et al. · Expert Opinion on Investigational Drugs · 1
Low Uptake of Hydroxyurea among a Cohort of Sickle Cell Disease Patients in Nigeria
2023 · Helen Chioma Okoye, Chilota Chibuife Efobi, et al. · Nigerian Journal of Medicine · 1
Glucose-6-Phosphate Dehydrogenase (G6PD) African A− Variant and Clinical Severity of Homozygous Sickle Cell Disease: A Prospective Descriptive Study
2026 · Osita Ezenwosu, Chinedu A. Ezekekwu, et al. · International Journal of Medicine and Health Development
Generalizability and variability in tranexamic acid dosage and efficacy in postpartum haemorrhage
2026 · Chioma Ejezie, Helen Okoye, et al. · Research Square
PDF
PB1641 Efficacy and Safety of Anticoagulation in Thrombocytopenic Patients With Cancer: A Systematic Review and Meta-analysis
2026 · Helen Okoye, Chioma Ejezie, et al. · Research and Practice in Thrombosis and Haemostasis
PDF
Adult Patients with HbS-Only Phenotype of Sickle Cell Disease Have a Decreased Arginine/Asymmetric Dimethylarginine Ratio
2025 · Chiemelie Raluchukwu Onwasigwe, Angela Ogechukwu Ugwu, et al. · Medical Principles and Practice
PDF
Attributes of Pathological Fractures in a Nigerian myeloma cohort
2024 · Augustine Nwakuche Duru, Charles Emeka Nonyelu, et al. · Annals of Clinical and Biomedical Research
PDF
Impact of Binet Staging versus Tumour Bulk on Treatment Outcome in Chronic Lymphocytic Leukaemia
2024 · Anazoeze Jude Madu, Helen Chioma Okoye, et al. · Nigerian Postgraduate Medical Journal
Impact of Medical Approach in a Limited-resources Centre on the Pattern of Sickle Cell Disease Phenotypes and its Complication in a Nigerian Hospital: A Single-center Retrospective Study
2021 · A.N. Duru, R. Okebaram, et al. · Journal of Advances in Medicine and Medical Research
Works count: 20
Citation count: 49
H-index: 5
I10-index:
Year
Topic
Type